BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26405809)

  • 21. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
    Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interfractional positional variability of fiducial markers and primary tumors in locally advanced non-small-cell lung cancer during audiovisual biofeedback radiotherapy.
    Roman NO; Shepherd W; Mukhopadhyay N; Hugo GD; Weiss E
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1566-72. PubMed ID: 22391105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adaptive radiotherapy planning on decreasing gross tumor volumes as seen on megavoltage computed tomography images.
    Woodford C; Yartsev S; Dar AR; Bauman G; Van Dyk J
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1316-22. PubMed ID: 17967322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetric advantages of four-dimensional adaptive image-guided radiotherapy for lung tumors using online cone-beam computed tomography.
    Harsolia A; Hugo GD; Kestin LL; Grills IS; Yan D
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):582-9. PubMed ID: 18207034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
    Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
    Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical study of shrinking field radiation therapy based on (18)F-FDG PET/CT for stage III non-small cell lung cancer.
    Ding X; Li H; Wang Z; Huang W; Li B; Zang R; Sun H; Yi Y
    Technol Cancer Res Treat; 2013 Jun; 12(3):251-7. PubMed ID: 23289475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of normal lung irradiation in locally advanced non-small-cell lung cancer patients, using ventilation images for functional avoidance.
    Yaremko BP; Guerrero TM; Noyola-Martinez J; Guerra R; Lege DG; Nguyen LT; Balter PA; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):562-71. PubMed ID: 17398028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential chemoradiotherapy with accelerated hypofractionated radiotherapy compared to concurrent chemoradiotherapy with standard radiotherapy for locally advanced non-small cell lung cancer.
    Zhu ZF; Ma HL; Fan M; Bao Y; Zhuang TT; Chen M; Jiang GL; Fu XL
    Technol Cancer Res Treat; 2014 Jun; 13(3):269-75. PubMed ID: 24066952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is tumor volume reduction during radiotherapy prognostic relevant in patients with stage III non-small cell lung cancer?
    Elsayad K; Samhouri L; Scobioala S; Haverkamp U; Eich HT
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1165-1171. PubMed ID: 29623466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation dose response of normal lung assessed by Cone Beam CT - a potential tool for biologically adaptive radiation therapy.
    Bertelsen A; Schytte T; Bentzen SM; Hansen O; Nielsen M; Brink C
    Radiother Oncol; 2011 Sep; 100(3):351-5. PubMed ID: 21903286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic radiotherapy using tomotherapy for early-stage non-small cell lung carcinoma: analysis of intrafraction tumour motion.
    Boggs DH; Feigenberg S; Walter R; Wissing D; Patel B; Wu T; Rosen L
    J Med Imaging Radiat Oncol; 2014 Dec; 58(6):706-13. PubMed ID: 24767098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of respiration induced intra- and inter-fractional tumour motion using a standard Cone Beam CT.
    Gottlieb KL; Hansen CR; Hansen O; Westberg J; Brink C
    Acta Oncol; 2010 Oct; 49(7):1192-8. PubMed ID: 20831512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Are there any dosimetric advantages in using VMAT for treatment of locally advanced non-small cell lung cancer?].
    Rousseau D; Autret D; Krhili S; Yossi S; Dupas A; Edouard M; Mahé MA; Giraud P; Le Péchoux C; Cellier P; Denis F; Paumier A
    Cancer Radiother; 2012 Oct; 16(7):619-26. PubMed ID: 23089069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating tumor response of non-small cell lung cancer patients with ¹⁸F-fludeoxyglucose positron emission tomography: potential for treatment individualization.
    Toma-Dasu I; Uhrdin J; Lazzeroni M; Carvalho S; van Elmpt W; Lambin P; Dasu A
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):376-84. PubMed ID: 25636761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor Shrinkage During Chemoradiation in Locally Advanced Cervical Cancer Patients: Prognostic Significance, and Impact for Image-Guided Adaptive Brachytherapy.
    Schernberg A; Bockel S; Annede P; Fumagalli I; Escande A; Mignot F; Kissel M; Morice P; Bentivegna E; Gouy S; Deutsch E; Haie-Meder C; Chargari C
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):362-372. PubMed ID: 29920324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
    van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy.
    Kwint M; Uyterlinde W; Nijkamp J; Chen C; de Bois J; Sonke JJ; van den Heuvel M; Knegjens J; van Herk M; Belderbos J
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e223-8. PubMed ID: 22560551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer.
    Britton KR; Starkschall G; Liu H; Chang JY; Bilton S; Ezhil M; John-Baptiste S; Kantor M; Cox JD; Komaki R; Mohan R
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):94-102. PubMed ID: 18929448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.